[Penetration of ciprofloxacin and cefoperazone into human pancreas].
Major pancreatic infection is responsible for more than 80% of deaths in patients with acute pancreatitis. Therefore, the role of antimicrobial drugs in the prevention and treatment of secondary parcreatic infection is very important. The choice of antimicrobial drugs must be based upon the ability of the drug to exceed the therapeutic concentration in pancreas for the common pathogens. The penetration of ciprofloxacin and cefoperazone into pancreas was investigated in ten patients who had undergone pancreatoduodenectomy. The pancreatic juice was temporarily diverted to the exterior via a panoreatic duct catheter. The pancreatic tissue was obtained intraoperatively and pancreatic juice was drained postoperatively. The antimicrobial drug concentrations were determined by high-performance liquid chromatography. The concentrations of ciprofloxacin and cefoperazone in pancreatic juice were 44% and 17%, respectively, of those in serum, and exceeded the in vitro concentration (MIC-90) for most bacteria associated with pancreatic infections. The result indicates that ciprofloxacin and cefoprazone appear to be appropriate for both prophylaxis and therapy of secondary pancreatic infections.
Jiang
L
L
Hepato-Pancreato-Biliary Research Unit, First Affiliated Hospital, Chengdu.
Peng
Q
Q
Yao
Y
Y
D000328:Adult; D014670:Ampulla of Vater; D000890:Anti-Infective Agents / Q000493:pharmacokinetics; D002438:Cefoperazone / Q000493:pharmacokinetics*; D002511:Cephalosporins / Q000493:pharmacokinetics*; D002939:Ciprofloxacin / Q000493:pharmacokinetics*; D003138:Common Bile Duct Neoplasms / Q000378:metabolism; D006801:Humans; D008875:Middle Aged; D010179:Pancreas / Q000378:metabolism*; D010189:Pancreatic Juice / Q000378:metabolism; D010195:Pancreatitis / Q000517:prevention & control
D000890:Anti-Infective Agents; D002511:Cephalosporins; D002939:Ciprofloxacin; D002438:Cefoperazone